Food allergy management has become an important issue with the rise of food allergies in the world. Food allergy affects up to 8% of school age children and management has become a major public health issue. Consensus guidelines recommend that all students at risk for anaphylaxis due to food allergy have an individualized emergency action […]
AR101 a Potential Peanut Allergy Cure
AR101 is currently being studied by Aimmune Therapeutics to induce desensitization in peanut allergic subjects. The peanut treatment, AR101, passed through phase 2 trials in 2016, protecting 100% of patients who ate 443 mg of peanuts (1.5 peanuts), 90% of those who ate 1,043 mg (3 peanuts) and 60% who ate 2,043 mg (7 peanuts). A single […]
Epinephrine Prescriptions after Anaphylaxis
National guidelines recommend that patients with anaphylaxis be prescribed an epinephrine auto-injector (i.e. EpiPen) and referred to an allergy specialist. In this study we look at what percentage of patients are given epinephrine injectors and referred to see an allergy doctor upon discharge from the emergency room after an anaphylaxis episode. Anaphylaxis is a life […]
Auvi-Q 0.1 mg dose approved for infants and children
Auvi-Q 0.1 mg dose was recently approved by the FDA for infants and small children weighing 16.5-33 pounds. Currently there are only 2 dosages on the market for injectable epinephrine, 0.15 mg and 0.3 mg. The 0.3 mg dose is for anyone over 66 pounds and 0.15 mg for anyone below it. There was an […]
EpiPen Failure, can epinephrine injectors improve?
The FDA has reported 228 complaints and 7 deaths this year for possible Epipen failure. The FDA received 4 complaints in 2012 for Epipen failure. They also reported 35 cases of hospitalizations. The FDA warned: “There is no certainty that the reported event … was due to the product.” Epipen Failure News Link Food related […]
When do I use my Epipen?
When do I use my Epipen is a question commonly asked among patients who have food allergies. During the past 20 years food allergy has dramatically increased with an increase risk for anaphylaxis. Anaphylaxis is defined as “a serious allergic reaction that is rapid in onset and may cause death.” Foods are on of the […]
Symjepi a cheaper alternative to Epipen, FDA Approved
Symjepi was recently approved by the FDA that will directly compete with other injectable epinephrine medications. Symjepi will be manufactured by Adamis Pharamceuticals Corporation. Symjepi will come as 2 single dose syringes of 0.3 milligrams of epinephrine, a life saving medication for those allergic to bee stings, food allergies, medication allergies or anyone suffering from […]
Auvi-Q to return to market
Auvi-Q is set to return to the market February 14, 2017. Auvi-Q was withdrawn off the market in the past because improper dosing and later it was sold to Kaleo. Auvi-Q Recall Many were wondering if Auvi-Q would ever return to the market again. Many patients liked the small packaging and the fact that it […]
Anaphylaxis with Xolair, a Case Study
Anaphylaxis with Xolair is a rare occurrence, approximately 0.2%. A recent study published in the Journal of Allergy and Clinical Immunology titled “Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control study” looked to clarify the circumstances and risk factors associated with anaphylaxis to Xolair. Xolair or omalizumab is indicated for moderate to severe […]
Why is the Epipen Price so High?
The Epipen price has sparked an outrage among consumers and lawmakers who worry that parents won’t be able to afford them for children heading back to school. It is used for those who suffer from life threatening reactions to bee stings, peanuts and other allergens. In 2007, the price for a two-pen set was less […]